Barzolvolimab (Synonyms: CDX 0159) |
| Catalog No.GC68727 |
Barzolvolimab (CDX 0159) est un anticorps monoclonal IgG1 humanisé anti-KIT. Barzolvolimab inhibe spécifiquement et efficacement l'activation de KIT. Barzolvolimab peut réduire les mastocytes cutanés et l'activité de la maladie dans l'urticaire chronique induite.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2438203-51-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Barzolvolimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Barzolvolimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *